(1->4)-beta-D-glucan multiple interactions ISO RGD:1320748 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of B4GALT5 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:1320748 6480464 ethylene dichloride results in decreased expression of B4GALT5 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of B4GALT5 mRNA CTD PMID:25380136 , PMID:30723492 17beta-estradiol increases expression ISO RGD:1320747 6480464 Estradiol results in increased expression of B4GALT5 mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1320748 6480464 2 more ... CTD PMID:34627992 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1320747 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of B4GALT5 mRNA CTD PMID:22298810 , PMID:34747641 2-butoxyethanol increases expression ISO RGD:1320748 6480464 n-butoxyethanol results in increased expression of B4GALT5 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:1320747 6480464 Lactic Acid results in increased expression of B4GALT5 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of B4GALT5 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1320747 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B4GALT5 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B4GALT5 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of B4GALT5 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases methylation ISO RGD:1320748 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of B4GALT5 promoter CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1320748 6480464 Fenretinide results in increased expression of B4GALT5 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of B4GALT5 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of B4GALT5 mRNA CTD PMID:33354967 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of B4GALT5 mRNA CTD PMID:20488242 all-trans-retinoic acid affects expression ISO RGD:1320748 6480464 Tretinoin affects the expression of B4GALT5 mRNA CTD PMID:34627992 all-trans-retinoic acid multiple interactions ISO RGD:1320748 6480464 2 more ... CTD PMID:34627992 all-trans-retinoic acid increases expression ISO RGD:1320747 6480464 Tretinoin results in increased expression of B4GALT5 mRNA CTD PMID:18052213 , PMID:33167477 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of B4GALT5 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:1320747 6480464 aristolochic acid I results in decreased expression of B4GALT5 mRNA CTD PMID:33212167 arsenite(3-) increases methylation ISO RGD:1320747 6480464 arsenite results in increased methylation of B4GALT5 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:1320747 6480464 Arsenic Trioxide results in decreased expression of B4GALT5 protein CTD PMID:18439752 arsenous acid decreases response to substance ISO RGD:1320747 6480464 B4GALT5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18439752 benzo[a]pyrene decreases expression ISO RGD:1320747 6480464 Benzo(a)pyrene results in decreased expression of B4GALT5 mRNA CTD PMID:20064835 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1320747 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene increases expression ISO RGD:1320748 6480464 benzo(b)fluoranthene results in increased expression of B4GALT5 mRNA CTD PMID:26377693 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of B4GALT5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1320748 6480464 bisphenol A results in increased expression of B4GALT5 mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A multiple interactions ISO RGD:1320747 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B4GALT5 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:1320747 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B4GALT5 mRNA CTD PMID:28628672 butan-1-ol multiple interactions ISO RGD:1320747 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of B4GALT5 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1320747 6480464 butyraldehyde results in decreased expression of B4GALT5 mRNA CTD PMID:26079696 carbon nanotube increases expression ISO RGD:1320748 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1320748 6480464 Nanotubes, Carbon results in decreased expression of B4GALT5 mRNA CTD PMID:25620056 carmustine decreases expression ISO RGD:1320747 6480464 Carmustine results in decreased expression of B4GALT5 mRNA CTD PMID:15980968 CGP 52608 multiple interactions ISO RGD:1320747 6480464 CGP 52608 promotes the reaction [RORA protein binds to B4GALT5 gene] CTD PMID:28238834 cisplatin decreases expression ISO RGD:1320747 6480464 Cisplatin results in decreased expression of B4GALT5 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1320747 6480464 cobaltous chloride results in decreased expression of B4GALT5 mRNA CTD PMID:19376846 cyclosporin A decreases expression ISO RGD:1320747 6480464 Cyclosporine results in decreased expression of B4GALT5 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:1320747 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B4GALT5 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B4GALT5 mRNA CTD PMID:28628672 diarsenic trioxide decreases response to substance ISO RGD:1320747 6480464 B4GALT5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18439752 diarsenic trioxide decreases expression ISO RGD:1320747 6480464 Arsenic Trioxide results in decreased expression of B4GALT5 protein CTD PMID:18439752 dicrotophos increases expression ISO RGD:1320747 6480464 dicrotophos results in increased expression of B4GALT5 mRNA CTD PMID:28302478 doxorubicin decreases expression ISO RGD:1320747 6480464 Doxorubicin results in decreased expression of B4GALT5 mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO RGD:1320748 6480464 epoxiconazole results in decreased expression of B4GALT5 mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1320748 6480464 Ethanol affects the expression of B4GALT5 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1320748 6480464 Ethanol affects the splicing of B4GALT5 mRNA CTD PMID:30319688 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of B4GALT5 mRNA CTD PMID:28263823 furan increases expression EXP 6480464 furan results in increased expression of B4GALT5 mRNA CTD PMID:26194646 genistein decreases expression ISO RGD:1320748 6480464 Genistein results in decreased expression of B4GALT5 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of B4GALT5 mRNA CTD PMID:22061828 , PMID:33387578 hexadecanoic acid multiple interactions ISO RGD:1320747 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of B4GALT5 mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of B4GALT5 mRNA CTD PMID:30547786 indometacin multiple interactions ISO RGD:1320747 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B4GALT5 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B4GALT5 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO RGD:1320747 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of B4GALT5 mRNA CTD PMID:29432896 levonorgestrel multiple interactions ISO RGD:1320747 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of B4GALT5 mRNA CTD PMID:19074003 lipopolysaccharide multiple interactions ISO RGD:1320747 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of B4GALT5 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1320747 6480464 Lipopolysaccharides results in increased expression of B4GALT5 mRNA CTD PMID:35811015 methyl methanesulfonate decreases expression ISO RGD:1320747 6480464 Methyl Methanesulfonate results in decreased expression of B4GALT5 mRNA CTD PMID:23649840 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of B4GALT5 mRNA CTD PMID:25380136 oleic acid multiple interactions ISO RGD:1320747 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of B4GALT5 mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of B4GALT5 mRNA CTD PMID:30547786 paracetamol increases expression ISO RGD:1320747 6480464 Acetaminophen results in increased expression of B4GALT5 mRNA CTD PMID:22230336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of B4GALT5 mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of B4GALT5 mRNA CTD PMID:32680482 perfluorononanoic acid increases expression ISO RGD:1320747 6480464 perfluoro-n-nonanoic acid results in increased expression of B4GALT5 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1320748 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of B4GALT5 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of B4GALT5 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1320747 6480464 perfluorooctane sulfonic acid results in increased expression of B4GALT5 mRNA CTD PMID:25812627 perfluorooctanoic acid increases expression ISO RGD:1320747 6480464 perfluorooctanoic acid results in increased expression of B4GALT5 mRNA CTD PMID:25812627 rac-lactic acid increases expression ISO RGD:1320747 6480464 Lactic Acid results in increased expression of B4GALT5 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of B4GALT5 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1320747 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of B4GALT5 mRNA] CTD PMID:35811015 sodium arsenite affects expression ISO RGD:1320747 6480464 sodium arsenite affects the expression of B4GALT5 mRNA CTD PMID:34032870 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of B4GALT5 mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of B4GALT5 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1320748 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of B4GALT5 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of B4GALT5 mRNA CTD PMID:21641980 , PMID:26378955 tamoxifen increases expression ISO RGD:1320748 6480464 Tamoxifen results in increased expression of B4GALT5 mRNA CTD PMID:25123088 testosterone undecanoate multiple interactions ISO RGD:1320747 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of B4GALT5 mRNA CTD PMID:19074003 tetraphene decreases expression ISO RGD:1320748 6480464 benz(a)anthracene results in decreased expression of B4GALT5 mRNA CTD PMID:26377693 thapsigargin increases expression ISO RGD:1320747 6480464 Thapsigargin results in increased expression of B4GALT5 mRNA CTD PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of B4GALT5 mRNA CTD PMID:23411599 , PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of B4GALT5 mRNA CTD PMID:33387578 tunicamycin decreases expression ISO RGD:1320747 6480464 Tunicamycin results in decreased expression of B4GALT5 mRNA CTD PMID:22378314 valproic acid increases methylation ISO RGD:1320747 6480464 Valproic Acid results in increased methylation of B4GALT5 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1320747 6480464 Valproic Acid results in increased expression of B4GALT5 mRNA CTD PMID:19101580 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of B4GALT5 mRNA CTD PMID:23034163
